NHS National Pharmaceuticals - Everolimus and terminated agreement products
Estimated value
£4.5m
Awarded value
£4.5m
Suppliers
1
Lots
1
Published
20 Oct 2021
Description
Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement products Offer reference number: CM/PHG/21/5632 Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Potential periods of call-offs under the framework agreement: Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022 Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022 Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022
Scope
- Reference
- CF-0272400D0O000000rwimUAA1
- Total value
- £4,516,089 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 14 May 2021 to 01 Mar 2022
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 26 Apr 2021, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£4.5m
Award date
07 Jun 2021
Contract start
14 May 2021
Contract end
01 Mar 2022